尹桂林, 李燕, 唐克, 金小锋, 陈晓光, 李莉, 冯志强. 2-(3-丁炔酰胺基苯基) 苯并噻唑衍生物的合成及抗肿瘤活性研究J. 药学学报, 2014,49(6): 888-895.
引用本文: 尹桂林, 李燕, 唐克, 金小锋, 陈晓光, 李莉, 冯志强. 2-(3-丁炔酰胺基苯基) 苯并噻唑衍生物的合成及抗肿瘤活性研究J. 药学学报, 2014,49(6): 888-895.
YIN Gui-lin, LI Yan, TANG Ke, JIN Xiao-feng, CHEN Xiao-guang, LI Li, FENG Zhi-qiang. Synthesis and biological evaluation of 2-(3-butynoicamidophenyl) benzothiazole derivatives as antitumor agentsJ. Acta Pharmaceutica Sinica, 2014,49(6): 888-895.
Citation: YIN Gui-lin, LI Yan, TANG Ke, JIN Xiao-feng, CHEN Xiao-guang, LI Li, FENG Zhi-qiang. Synthesis and biological evaluation of 2-(3-butynoicamidophenyl) benzothiazole derivatives as antitumor agentsJ. Acta Pharmaceutica Sinica, 2014,49(6): 888-895.

2-(3-丁炔酰胺基苯基) 苯并噻唑衍生物的合成及抗肿瘤活性研究

Synthesis and biological evaluation of 2-(3-butynoicamidophenyl) benzothiazole derivatives as antitumor agents

  • 摘要: 以4-氟-3-硝基苯甲酸为起始原料,通过两条合成路线,经5~7步反应得到20个全新的2-(3-丁炔酰胺基苯基)苯并噻唑类化合物。目标化合物的结构经1H NMR和HR-MS鉴定。采用MTT法考察了其对5种肿瘤细胞株(HCT116、Mia-PaCa2、U87-MG、A549、NCI-H1975)的抗增殖作用,结果表明大部分化合物选择性地对其中的3种肿瘤细胞具有明显的抗增殖活性,其中化合物14c对人脑胶质母细胞瘤U87-MG细胞、化合物14h对结肠癌HCT116细胞的IC50值均在1×10-8 mol·L-1数量级水平,在此基础上对该类化合物进行了初步构效分析。

     

    Abstract: A series of 2-(3-butynoicamidophenyl)benzothiazole derivatives were synthesized starting from 4-fluoro-3-nitrobenzoic acid.Structures of all the synthesized compounds were confirmed by 1H NMR and HR-MS.Their antitumor activities against human tumor cells lines (HCT116, Mia-PaCa2, U87-MG, A549, NCI-H1975) were evaluated by MTT assay.The results revealed that most of the synthesized compounds showed potent activities against HCT116, Mia-PaCa2, U87-MG tumor cells lines.Particularly, compounds 14c and 14h exhibited better activity with IC50 values of 1×10-8 mol·L-1 against U87-MG and HCT116 respectively.The structure-activity relationship of compounds was also discussed preliminarily.

     

/

返回文章
返回